Writing Your Legacy

As we age, especially for those of us who have advanced and recurrent prostate cancer we need to "put our affairs in order". This includes making sure we have a valid Will, have established any trusts that our spouses, partners, children and grandchildren might need, signed a health care proxy and appointed an individual with [...]

Genetic Variant Associated With Aggressive Prostate Cancer

The American Association of Cancer Researchers (AACR) is in the midst of its annual scientific research meeting in Denver Colorado. As interesting prostate cancer specific information becomes available I will try and share the news. One of the biggest concerns we face in prostate cancer is in deciding when a cancer needs to be treated. [...]

Contact Your Senators Today – Help Raise Prostate Cancer Research Funding

A letter from Sens. Tim Johnson (D-SD) and Mike Crapo (R-ID) is circulating in the Senate now and will be sent to the Defense Appropriations Subcommittee on Friday, April 24. Contact your Senators today and ask them to sign the Johnson-Crapo Appropriations letter to increase research funding for prostate cancer at the Department of Defense. [...]

National Cancer Institute’s (NCI) Plan to Accelerate Cancer Research Announced

At the American Association for Cancer Research 100th Annual Meeting 2009 in Denver, National Cancer Institute (NCI) Director John E. Niederhuber, M.D., announced major details, such as funding more grants, development of a platform for personalized cancer care, and an accelerated cancer genetics program, that will move cancer research forward in this new economic environment. [...]

Long-Term Effects of Intermittent Androgen Suppression on Testosterone Recovery and Bone Mineral Density: Results of a 33-Month Observational Study

A phase II trial was just completed at the University of Western Australia to investigate changes in bone mineral density (BMD) and osteoporosis in men on intermittent androgen-suppression therapy (IAST) over a period of three years. This trial, conducted at the Faculty of Medicine, University of Western Australia, Crawley, Department of Radiation Oncology, Sir Charles [...]

Go to Top